Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02210


Purpose:

A Phase 1 study to evaluate the pharmacokinetics of ITCA 650 in subjects with mild and moderate renal impairment compared to the pharmacokinetics of subjects with normal renal function


Criteria:

Inclusion Criteria: - Body mass index between 22 and 40 kg/m² - Subjects meeting pre-defined estimated glomerular filtration rate criteria and creatinine clearance rate - Normal (≥90 mL/min/1.73 m2) - Mild (60-89 mL/min/1.73 m2) - Moderate (45-59 mL/min/1.73 m2) - Moderate (>30-44 mL/min/1.73 m2) Exclusion Criteria: - History of acute metabolic complications - Uncontrolled Hypertension - History of Hypersensitivity to Exenatide - Cardiovascular Disease - History of Acute or chronic pancreatitis - Personal or family history of Multiple endocrine neoplasia type 2 - History of Medullary thyroid cancer - Severe renal failure, End stage renal disease or dialysis


NCT ID:

NCT02320045


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02210
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.